FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3178201716> ?p ?o ?g. }

• W3178201716 endingPage "2189" @default.
• W3178201716 startingPage "2180" @default.
• W3178201716 abstract "The objective of this study was to determine whether two commonly prescribed antiseizure medications (ASMs), levetiracetam (LEV) and oxcarbazepine (OXC), were associated with an increased risk of fragility fracture in children with epilepsy when initiating therapy during a crucial period of bone development, namely, pre- and midpuberty.Claims data from January 1, 2009 to December 31, 2018 were extracted from the Optum Clinformatics Data Mart. Children aged 4-13 years at baseline with at least 5 years of continuous health plan enrollment were included to allow for a 1-year baseline (e.g., pre-ASM exposure) and 4 years of follow-up. Children with epilepsy who were ASM naïve were grouped based on whether ASM treatment initiation included LEV or OXC. The comparison group included children without epilepsy and without ASM exposure. Crude incidence rate (IR; n per 1000 person-years) and IR ratio (IRR; with 95% confidence interval [CI]) were estimated for nontrauma fracture (NTFx), a claims-based proxy for fragility fracture, for up to 4 years of follow-up. Cox proportional hazards regression estimated the hazard ratio (HR; with 95% CI) after adjusting for demographic variables, motor impairment, and baseline fracture.The crude IR (95% CI) of NTFx was 21.5 (21.2-21.8) for non-ASM-users without epilepsy (n = 271 346), 19.8 (12.3-27.2) for LEV (n = 358), and 34.4 (21.1-47.7) for OXC (n = 203). Compared to non-ASM-users, the crude IRR of NTFx was similar for LEV (IRR = .92, 95% CI = .63-1.34) and elevated for OXC (IRR = 1.60, 95% CI = 1.09-2.35); the crude IRR of NTFx was elevated for OXC compared to LEV (IRR = 1.74, 95% CI = 1.02-2.99). The findings were consistent after adjusting for covariates, except when comparing OXC to LEV (HR = 1.71, 95% CI = .99-2.93), which was marginally statistically insignificant (p = .053).Initiating OXC, but not LEV, therapy among 4-13-year-olds with epilepsy is associated with an elevated risk of fragility fracture. Studies are needed to determine whether these children could benefit from adjunct bone fragility therapies." @default.
• W3178201716 created "2021-07-19" @default.
• W3178201716 creator A5013069001 @default.
• W3178201716 creator A5021492844 @default.
• W3178201716 creator A5021858264 @default.
• W3178201716 creator A5084305608 @default.
• W3178201716 creator A5089509382 @default.
• W3178201716 date "2021-07-12" @default.
• W3178201716 modified "2023-10-17" @default.
• W3178201716 title "Effect of levetiracetam and oxcarbazepine on 4‐year fragility fracture risk among prepubertal and pubertal children with epilepsy" @default.
• W3178201716 cites W1480870442 @default.
• W3178201716 cites W1878275811 @default.
• W3178201716 cites W1978777334 @default.
• W3178201716 cites W1984554331 @default.
• W3178201716 cites W1987491143 @default.
• W3178201716 cites W1993033621 @default.
• W3178201716 cites W1997993986 @default.
• W3178201716 cites W2002280913 @default.
• W3178201716 cites W2013683193 @default.
• W3178201716 cites W2022694406 @default.
• W3178201716 cites W2048321750 @default.
• W3178201716 cites W2048567856 @default.
• W3178201716 cites W2063563320 @default.
• W3178201716 cites W2064217231 @default.
• W3178201716 cites W2065001720 @default.
• W3178201716 cites W2065505734 @default.
• W3178201716 cites W2069926335 @default.
• W3178201716 cites W2077256659 @default.
• W3178201716 cites W2086221746 @default.
• W3178201716 cites W2094605007 @default.
• W3178201716 cites W2116618585 @default.
• W3178201716 cites W2118085096 @default.
• W3178201716 cites W2122193655 @default.
• W3178201716 cites W2125210971 @default.
• W3178201716 cites W2129878014 @default.
• W3178201716 cites W2296761362 @default.
• W3178201716 cites W2345767082 @default.
• W3178201716 cites W2514269202 @default.
• W3178201716 cites W2530376686 @default.
• W3178201716 cites W2748150722 @default.
• W3178201716 cites W2752519588 @default.
• W3178201716 cites W2762402538 @default.
• W3178201716 cites W2808260620 @default.
• W3178201716 cites W2898551097 @default.
• W3178201716 cites W2953167344 @default.
• W3178201716 cites W2964753358 @default.
• W3178201716 cites W2972042810 @default.
• W3178201716 cites W3007296169 @default.
• W3178201716 cites W3028061577 @default.
• W3178201716 cites W3040379696 @default.
• W3178201716 cites W3094120544 @default.
• W3178201716 cites W3107375967 @default.
• W3178201716 cites W3157216201 @default.
• W3178201716 cites W4249207821 @default.
• W3178201716 doi "https://doi.org/10.1111/epi.16998" @default.
• W3178201716 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34250606" @default.
• W3178201716 hasPublicationYear "2021" @default.
• W3178201716 type Work @default.
• W3178201716 sameAs 3178201716 @default.
• W3178201716 citedByCount "3" @default.
• W3178201716 countsByYear W31782017162023 @default.
• W3178201716 crossrefType "journal-article" @default.
• W3178201716 hasAuthorship W3178201716A5013069001 @default.
• W3178201716 hasAuthorship W3178201716A5021492844 @default.
• W3178201716 hasAuthorship W3178201716A5021858264 @default.
• W3178201716 hasAuthorship W3178201716A5084305608 @default.
• W3178201716 hasAuthorship W3178201716A5089509382 @default.
• W3178201716 hasBestOaLocation W31782017162 @default.
• W3178201716 hasConcept C118552586 @default.
• W3178201716 hasConcept C126322002 @default.
• W3178201716 hasConcept C187212893 @default.
• W3178201716 hasConcept C207103383 @default.
• W3178201716 hasConcept C2777332695 @default.
• W3178201716 hasConcept C2778186239 @default.
• W3178201716 hasConcept C2779253243 @default.
• W3178201716 hasConcept C2781176495 @default.
• W3178201716 hasConcept C44249647 @default.
• W3178201716 hasConcept C50382708 @default.
• W3178201716 hasConcept C71924100 @default.
• W3178201716 hasConceptScore W3178201716C118552586 @default.
• W3178201716 hasConceptScore W3178201716C126322002 @default.
• W3178201716 hasConceptScore W3178201716C187212893 @default.
• W3178201716 hasConceptScore W3178201716C207103383 @default.
• W3178201716 hasConceptScore W3178201716C2777332695 @default.
• W3178201716 hasConceptScore W3178201716C2778186239 @default.
• W3178201716 hasConceptScore W3178201716C2779253243 @default.
• W3178201716 hasConceptScore W3178201716C2781176495 @default.
• W3178201716 hasConceptScore W3178201716C44249647 @default.
• W3178201716 hasConceptScore W3178201716C50382708 @default.
• W3178201716 hasConceptScore W3178201716C71924100 @default.
• W3178201716 hasFunder F4320312512 @default.
• W3178201716 hasIssue "9" @default.
• W3178201716 hasLocation W31782017161 @default.
• W3178201716 hasLocation W31782017162 @default.
• W3178201716 hasLocation W31782017163 @default.
• W3178201716 hasOpenAccess W3178201716 @default.
• W3178201716 hasPrimaryLocation W31782017161 @default.
• W3178201716 hasRelatedWork W110204841 @default.

• next